|
DE257197C
(https=)
|
|
|
|
|
|
DE286509C
(https=)
|
|
|
|
|
|
US3914252A
(en)
|
1971-03-15 |
1975-10-21 |
Continental Oil Co |
Preparation of N-iodocompounds
|
|
DD257197A1
(de)
|
1987-01-28 |
1988-06-08 |
Univ Dresden Tech |
Verfahren zur herstellung von immobilisierten, in ihrer biologischen aktivitaet stabilisierten und in ihren pharmakologischen eigenschaften modifizierten insulinpraeparationen
|
|
DK105489D0
(da)
|
1989-03-03 |
1989-03-03 |
Novo Nordisk As |
Polypeptid
|
|
DD286509A5
(de)
|
1989-06-30 |
1991-01-31 |
Veb Berlin-Chemie,De |
Verfahren zur herstellung von aktivitaetsstabilisierten, wirkungsverlaengerten rektal applizierbaren insulinpraeparationen
|
|
SE509359C2
(sv)
|
1989-08-01 |
1999-01-18 |
Cemu Bioteknik Ab |
Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
|
|
CA2405246A1
(en)
|
1990-12-03 |
1992-06-11 |
Genentech, Inc. |
Enrichment method for variant proteins with alterred binding properties
|
|
US6500645B1
(en)
|
1994-06-17 |
2002-12-31 |
Novo Nordisk A/S |
N-terminally extended proteins expressed in yeast
|
|
ZA954983B
(en)
|
1994-06-17 |
1996-02-14 |
Novo Nordisk As |
N-terminally extended proteins expressed in yeast
|
|
CA2230492C
(en)
|
1995-09-21 |
2009-05-26 |
Genentech, Inc. |
Human growth hormone variants
|
|
WO1998022577A1
(en)
|
1996-11-15 |
1998-05-28 |
Maria Grazia Masucci |
Fusion proteins having increased half-lives
|
|
EP0946735B1
(en)
|
1996-12-20 |
2006-02-08 |
Novo Nordisk A/S |
N-terminally extended proteins expressed in yeast
|
|
ATE375363T1
(de)
|
1997-07-14 |
2007-10-15 |
Bolder Biotechnology Inc |
Derivate des wachstumshormons und verwandte proteine
|
|
ATE407697T1
(de)
|
1999-07-13 |
2008-09-15 |
Bolder Biotechnology Inc |
Erythropoietin immunglobulin fusionsproteine
|
|
US20050287153A1
(en)
|
2002-06-28 |
2005-12-29 |
Genentech, Inc. |
Serum albumin binding peptides for tumor targeting
|
|
EP2180054A1
(en)
|
1999-12-24 |
2010-04-28 |
Genentech, Inc. |
Methods and compositions for prolonging elimination half-times of bioactive compounds
|
|
EP1352062A2
(en)
|
2001-01-11 |
2003-10-15 |
Maxygen Aps |
Improved growth hormone molecules
|
|
US20060183197A1
(en)
|
2001-01-11 |
2006-08-17 |
Andersen Kim V |
Variant growth hormone molecules conjugated with macromolecules compounds
|
|
PE20020908A1
(es)
|
2001-03-21 |
2002-10-26 |
Cell Therapeutics Inc |
Produccion recombinante de polimeros polianionicos y uso de de los mismos
|
|
US20050233417A1
(en)
|
2001-11-12 |
2005-10-20 |
Cooper David N |
Growth hormone variations in humans and their uses
|
|
GB2389115B
(en)
|
2001-12-14 |
2005-03-16 |
Asterion Ltd |
Polypeptide having a plurality of modified growth hormone receptor binding domains of growth hormone
|
|
WO2004029207A2
(en)
|
2002-09-27 |
2004-04-08 |
Xencor Inc. |
Optimized fc variants and methods for their generation
|
|
US20040180054A1
(en)
|
2003-03-13 |
2004-09-16 |
Hanmi Pharm. Co., Ltd. |
Physiologically active polypeptide conjugate having prolonged in vivo half-life
|
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
|
ATE555133T1
(de)
|
2003-11-13 |
2012-05-15 |
Hanmi Holdings Co Ltd |
Igg fc fragment für einen arzneimittelträger und verfahren zu dessen herstellung
|
|
KR100594607B1
(ko)
|
2004-11-03 |
2006-06-30 |
재단법인서울대학교산학협력재단 |
신규한 경구투여용 재조합 인간 성장호르몬 분비미생물제제 및 그 제조방법
|
|
US7998930B2
(en)
|
2004-11-04 |
2011-08-16 |
Hanall Biopharma Co., Ltd. |
Modified growth hormones
|
|
WO2006081249A2
(en)
*
|
2005-01-25 |
2006-08-03 |
Cell Therapeutics, Inc. |
Conjugates of biologically active proteins having a modified in vivo half-life
|
|
ZA200707006B
(en)
*
|
2005-01-25 |
2008-11-26 |
Cell Therapeutics Inc |
Conjugates of biologically active proteins having a modified in vivo half-life
|
|
EP1843790A2
(en)
|
2005-01-27 |
2007-10-17 |
Novo Nordisk A/S |
Insulin derivatives conjugated with structurally well defined branched polymers
|
|
BRPI0607775A2
(en)
|
2005-02-16 |
2018-06-26 |
Novo Nordisk A/S |
conjugate, pharmaceutical composition, use of a compound, and method for treating or preventing disease
|
|
KR100754667B1
(ko)
|
2005-04-08 |
2007-09-03 |
한미약품 주식회사 |
비펩타이드성 중합체로 개질된 면역글로불린 Ｆｃ 단편 및이를 포함하는 약제학적 조성물
|
|
WO2006116260A2
(en)
|
2005-04-26 |
2006-11-02 |
Medimmune, Inc. |
Modulation of antibody effector function by hinge domain engineering
|
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
|
US7855279B2
(en)
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
|
AU2006324488B2
(en)
|
2005-12-12 |
2013-03-21 |
Abcam Limited |
Production of conjugates
|
|
CN101384272B
(zh)
|
2005-12-20 |
2013-05-01 |
杜克大学 |
用于递送具有增强的药理性质的活性剂的方法和组合物
|
|
EP1996937A4
(en)
|
2006-03-06 |
2009-04-08 |
Amunix Inc |
GENETIC PACKS AND USES THEREOF
|
|
JP5256199B2
(ja)
|
2006-08-07 |
2013-08-07 |
テヴァ バイオファーマシューティカルズ ユーエスエー，インコーポレーティッド |
アルブミン−インスリン融合タンパク質
|
|
PT2094728E
(pt)
|
2006-10-26 |
2013-05-27 |
Janssen Biotech Inc |
Métodos de adaptação de anticorpos monoclonais ao ser humano
|
|
WO2008049711A1
(en)
*
|
2006-10-27 |
2008-05-02 |
Novo Nordisk A/S |
Peptide extended insulins
|
|
WO2008147456A2
(en)
|
2006-11-20 |
2008-12-04 |
Massachusetts Institute Of Technology |
Drug delivery systems using fc fragments
|
|
WO2008092117A2
(en)
|
2007-01-25 |
2008-07-31 |
Xencor, Inc. |
Immunoglobulins with modifications in the fcr binding region
|
|
KR20080095141A
(ko)
|
2007-04-23 |
2008-10-28 |
포항공과대학교 산학협력단 |
인간 알부민 링커를 통하여 면역글로불린의 Ｆｃ에 결합된생리학적 활성 폴리펩티드의 융합 폴리펩티드, 및 이의제조방법
|
|
CN105131127B
(zh)
|
2007-05-30 |
2018-09-07 |
浦项工科大学校产学协力团 |
免疫球蛋白融合蛋白
|
|
AU2008255352B2
(en)
|
2007-05-31 |
2014-05-22 |
Genmab A/S |
Stable IgG4 antibodies
|
|
WO2009015345A1
(en)
|
2007-07-25 |
2009-01-29 |
Amgen Inc. |
Pharmaceutical compositions comprising fc fusion proteins
|
|
US8933197B2
(en)
*
|
2007-08-15 |
2015-01-13 |
Amunix Operating Inc. |
Compositions comprising modified biologically active polypeptides
|
|
JP5314033B2
(ja)
|
2007-10-22 |
2013-10-16 |
メルク セローノ ソシエテ アノニム |
突然変異ＩｇＧＦｃフラグメントと融合した単一ＩＦＮ−ベータ
|
|
KR101784231B1
(ko)
|
2008-06-20 |
2017-11-08 |
노파르티스 아게 |
응집이 감소된 면역글로불린
|
|
US20110119848A1
(en)
|
2008-07-02 |
2011-05-26 |
Koninklijke Philips Electronics N.V. |
V-spring configuration and end attachment assemblies therefor for use in a personal care appliance
|
|
UA101670C2
(ru)
|
2008-07-23 |
2013-04-25 |
Ханми Сайенс Ко., Лтд. |
Полипептидный комплекс, содержащий непептидильный полимер, который имеет три функциональных конца
|
|
CA2748314C
(en)
*
|
2009-02-03 |
2018-10-02 |
Amunix Operating Inc. |
Extended recombinant polypeptides and compositions comprising same
|
|
GB0914110D0
(en)
|
2009-08-12 |
2009-09-16 |
Medical Res Council |
Peptide libraries
|
|
MX2012003939A
(es)
|
2009-09-30 |
2012-07-30 |
Glaxo Group Ltd |
Fusiones y conjugados de farmaco.
|
|
US20120276092A1
(en)
|
2009-10-29 |
2012-11-01 |
Jinquan Luo |
Antibody Glycosylation Variants
|
|
US8637637B2
(en)
|
2010-01-12 |
2014-01-28 |
Bill Nai-Chau Sun |
Fc fusion proteins of human growth hormone
|
|
AR081066A1
(es)
|
2010-04-02 |
2012-06-06 |
Hanmi Holdings Co Ltd |
Conjugado de insulina donde se usa un fragmento de inmunoglobulina
|
|
WO2011144756A1
(en)
|
2010-05-21 |
2011-11-24 |
Xl-Protein Gmbh |
Biosynthetic proline/alanine random coil polypeptides and their uses
|
|
KR101337797B1
(ko)
|
2010-07-14 |
2013-12-06 |
한미사이언스 주식회사 |
지속형 인간 성장 호르몬 결합체 액상 제제
|
|
US9783571B2
(en)
|
2011-04-05 |
2017-10-10 |
Warham Lance Martin |
Isolation of cysteine containing peptides
|
|
UA117901C2
(uk)
|
2011-07-06 |
2018-10-25 |
Ґенмаб Б.В. |
Спосіб посилення ефекторної функції вихідного поліпептиду, його варіанти та їх застосування
|
|
CN117462693A
(zh)
|
2012-02-27 |
2024-01-30 |
阿穆尼克斯运营公司 |
Xten缀合组合物和制造其的方法
|
|
CA2873112A1
(en)
|
2012-05-11 |
2013-11-14 |
Alexander Krantz |
Site-specific labeling and targeted delivery of proteins for the treatment of cancer
|
|
JP2016521701A
(ja)
|
2013-06-07 |
2016-07-25 |
ノヴォ ノルディスク アー／エス |
成熟インスリンポリペプチドを作製するための方法
|
|
CN105792851B
(zh)
|
2013-09-13 |
2023-10-10 |
斯克利普斯研究所 |
修饰的治疗剂及其组合物
|
|
JP6620094B2
(ja)
|
2013-11-26 |
2019-12-11 |
ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドＴｈｅ Ｂｒｉｇｈａｍ ａｎｄ Ｗｏｍｅｎ’ｓ Ｈｏｓｐｉｔａｌ， Ｉｎｃ． |
免疫応答を調節するための組成物および方法
|
|
TW201619188A
(zh)
|
2014-03-05 |
2016-06-01 |
優稀美生物醫藥公司 |
多聚體Ｆｃ蛋白質
|
|
CN106687482B
(zh)
|
2014-09-17 |
2022-01-25 |
诺和诺德股份有限公司 |
能够结合组织因子途径抑制剂(1-161)上的两个表位的抗体
|
|
US10894089B2
(en)
|
2015-02-17 |
2021-01-19 |
Hanmi Pharm. Co., Ltd. |
Long-acting insulin or insulin analogue conjugate
|
|
AR105616A1
(es)
|
2015-05-07 |
2017-10-25 |
Lilly Co Eli |
Proteínas de fusión
|
|
JP6983075B2
(ja)
|
2015-06-02 |
2021-12-17 |
ノヴォ ノルディスク アー／エス |
極性の組換え延長部を有するインスリン
|
|
CA2994853C
(en)
|
2015-08-14 |
2023-06-27 |
Rc Biotechnologies, Inc. |
Covalent linkers in antibody-drug conjugates and methods of making and using the same
|
|
CN108136043B
(zh)
|
2015-10-01 |
2022-09-06 |
诺和诺德股份有限公司 |
蛋白质缀合物
|
|
CN110505885A
(zh)
|
2017-04-05 |
2019-11-26 |
诺和诺德股份有限公司 |
寡聚体延伸的胰岛素-Fc缀合物
|